Literature DB >> 25368164

c-Abl tyrosine kinase promotes adipocyte differentiation by targeting PPAR-gamma 2.

Rom Keshet1, Zina Bryansker Kraitshtein1, Matan Shanzer1, Julia Adler1, Nina Reuven1, Yosef Shaul2.   

Abstract

Adipocyte differentiation, or adipogenesis, is a complex and highly regulated process. A recent proteomic analysis has predicted that the nonreceptor tyrosine kinase Abelson murine leukemia viral oncogene (c-Abl) is a putative key regulator of adipogenesis, but the underlying mechanism remained obscure. We found that c-Abl was activated during the early phase of mouse 3T3-L1 preadipocyte differentiation. Moreover, c-Abl activity was essential and its inhibition blocked differentiation to mature adipocytes. c-Abl directly controlled the expression and activity of the master adipogenic regulator peroxisome proliferator-activator receptor gamma 2 (PPARγ2). PPARγ2 physically associated with c-Abl and underwent phosphorylation on two tyrosine residues within its regulatory activation function 1 (AF1) domain. We demonstrated that this process positively regulates PPARγ2 stability and adipogenesis. Remarkably, c-Abl binding to PPARγ2 required the Pro12 residue that has a phenotypically well-studied common human genetic proline 12 alanine substitution (Pro12Ala) polymorphism. Our findings establish a critical role for c-Abl in adipocyte differentiation and explain the behavior of the known Pro12Ala polymorphism.

Entities:  

Keywords:  PPAR gamma; Pro12Ala polymorphism; adipogenesis; c-Abl; differentiation

Mesh:

Substances:

Year:  2014        PMID: 25368164      PMCID: PMC4246298          DOI: 10.1073/pnas.1411086111

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  44 in total

1.  Interdomain communication regulating ligand binding by PPAR-gamma.

Authors:  D Shao; S M Rangwala; S T Bailey; S L Krakow; M J Reginato; M A Lazar
Journal:  Nature       Date:  1998-11-26       Impact factor: 49.962

2.  A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis.

Authors:  P Puigserver; Z Wu; C W Park; R Graves; M Wright; B M Spiegelman
Journal:  Cell       Date:  1998-03-20       Impact factor: 41.582

3.  Isoform-specific functions of c-abl: type I is necessary for differentiation, and type IV is inhibitory to apoptosis.

Authors:  R Daniel; P M Wong; S W Chung
Journal:  Cell Growth Differ       Date:  1996-09

4.  An adipogenic cofactor bound by the differentiation domain of PPARgamma.

Authors:  G Castillo; R P Brun; J K Rosenfield; S Hauser; C W Park; A E Troy; M E Wright; B M Spiegelman
Journal:  EMBO J       Date:  1999-07-01       Impact factor: 11.598

5.  Molecular scanning of the human peroxisome proliferator activated receptor gamma (hPPAR gamma) gene in diabetic Caucasians: identification of a Pro12Ala PPAR gamma 2 missense mutation.

Authors:  C J Yen; B A Beamer; C Negri; K Silver; K A Brown; D P Yarnall; D K Burns; J Roth; A R Shuldiner
Journal:  Biochem Biophys Res Commun       Date:  1997-12-18       Impact factor: 3.575

6.  Abl expression in human fetal and adult tissues, tumours, and tumour microvessels.

Authors:  A J O'Neill; T G Cotter; J M Russell; E F Gaffney
Journal:  J Pathol       Date:  1997-11       Impact factor: 7.996

7.  Inhibition of adipogenesis through MAP kinase-mediated phosphorylation of PPARgamma.

Authors:  E Hu; J B Kim; P Sarraf; B M Spiegelman
Journal:  Science       Date:  1996-12-20       Impact factor: 47.728

8.  Phosphorylation of DNA topoisomerase I by the c-Abl tyrosine kinase confers camptothecin sensitivity.

Authors:  Donghui Yu; Ehsan Khan; Md Abdul Khaleque; James Lee; Gary Laco; Glenda Kohlhagen; Surender Kharbanda; Yung-Chi Cheng; Yves Pommier; Ajit Bharti
Journal:  J Biol Chem       Date:  2004-09-24       Impact factor: 5.157

9.  A Pro12Ala substitution in PPARgamma2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity.

Authors:  S S Deeb; L Fajas; M Nemoto; J Pihlajamäki; L Mykkänen; J Kuusisto; M Laakso; W Fujimoto; J Auwerx
Journal:  Nat Genet       Date:  1998-11       Impact factor: 38.330

10.  Interaction of c-Abl and p73alpha and their collaboration to induce apoptosis.

Authors:  R Agami; G Blandino; M Oren; Y Shaul
Journal:  Nature       Date:  1999-06-24       Impact factor: 49.962

View more
  10 in total

1.  c-Abl inhibition mitigates diet-induced obesity through improving insulin sensitivity of subcutaneous fat in mice.

Authors:  Rong Wu; Jian-Guang Sun; Ji-Qiu Wang; Binhua Li; Qingsong Liu; Guang Ning; Wanzhu Jin; Zengqiang Yuan
Journal:  Diabetologia       Date:  2017-01-10       Impact factor: 10.122

2.  An RNAi Screening of Clinically Relevant Transcription Factors Regulating Human Adipogenesis and Adipocyte Metabolism.

Authors:  Christel Björk; Narmadha Subramanian; Jianping Liu; Juan Ramon Acosta; Beatriz Tavira; Anders B Eriksson; Peter Arner; Jurga Laurencikiene
Journal:  Endocrinology       Date:  2021-07-01       Impact factor: 4.736

3.  c-Abl forces YAP to switch sides.

Authors:  Rom Keshet; Nina Reuven; Yosef Shaul
Journal:  Mol Cell Oncol       Date:  2015-01-23

4.  Investigations on Binding Pattern of Kinase Inhibitors with PPARγ: Molecular Docking, Molecular Dynamic Simulations, and Free Energy Calculation Studies.

Authors:  Mohit Mazumder; Prija Ponnan; Umashankar Das; Samudrala Gourinath; Haseeb Ahmad Khan; Jian Yang; Meena Kishore Sakharkar
Journal:  PPAR Res       Date:  2017-02-22       Impact factor: 4.964

5.  The E3 ubiquitin ligase TRIM25 regulates adipocyte differentiation via proteasome-mediated degradation of PPARγ.

Authors:  Jae Min Lee; Sun Sil Choi; Yo Han Lee; Keon Woo Khim; Sora Yoon; Byung-Gyu Kim; Dougu Nam; Pann-Ghill Suh; Kyungjae Myung; Jang Hyun Choi
Journal:  Exp Mol Med       Date:  2018-10-15       Impact factor: 8.718

6.  Inhibition of Notch Signaling Promotes the Differentiation of Epicardial Progenitor Cells into Adipocytes.

Authors:  Bin Liu; Dinghui Wang; Tianhua Xiong; Yajie Liu; Xiaodong Jing; Jianlin Du; Qiang She
Journal:  Stem Cells Int       Date:  2021-04-09       Impact factor: 5.443

7.  Genetics and Clinical Characteristics of PPARγ Variant-Induced Diabetes in a Chinese Han Population.

Authors:  Siqian Gong; Xueyao Han; Meng Li; Xiaoling Cai; Wei Liu; Yingying Luo; Si-Min Zhang; Lingli Zhou; Yumin Ma; Xiuting Huang; Yufeng Li; Xianghai Zhou; Yu Zhu; Qiuping Wang; Ling Chen; Qian Ren; Ping Zhang; Linong Ji
Journal:  Front Endocrinol (Lausanne)       Date:  2021-10-26       Impact factor: 5.555

8.  Over-expression of PPAR-γ2 gene enhances the adipogenic differentiation of hemangioma-derived mesenchymal stem cells in vitro and in vivo.

Authors:  Si-Ming Yuan; Yao Guo; Qian Wang; Yuan Xu; Min Wang; Hai-Ni Chen; Wei-Min Shen
Journal:  Oncotarget       Date:  2017-12-26

9.  KMUP-1, a GPCR Modulator, Attenuates Triglyceride Accumulation Involved MAPKs/Akt/PPARγ and PKA/PKG/HSL Signaling in 3T3-L1 Preadipocytes.

Authors:  Chung-Pin Liu; Pei-Chun Chau; Chain-Ting Chang; Li-Mei An; Jwu-Lai Yeh; Ing-Jun Chen; Bin-Nan Wu
Journal:  Molecules       Date:  2018-09-23       Impact factor: 4.411

10.  Peroxisome proliferator-activated receptor gamma as a theragnostic target for mesenchymal-type glioblastoma patients.

Authors:  Tuyen N M Hua; Jiwoong Oh; Sohyun Kim; Jayson M Antonio; Vu T A Vo; Jiyeon Om; Jong-Whan Choi; Jeong-Yub Kim; Chan-Woong Jung; Myung-Jin Park; Yangsik Jeong
Journal:  Exp Mol Med       Date:  2020-04-13       Impact factor: 8.718

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.